海外の治験の状況「%E8%84%B3%E5%8D%92%E4%B8%AD」での検索結果
153件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not recruiting
- A Study of the Safety and Efficacy of Anacetrapib (MK-0859) Among Participants With Hypercholesterolemia When Added to Ongoing Statin Therapy (MK-0859-022)
- Hypercholesterolemia
- Brazil, China, Korea, Republic of, Mexico, Russian Federation, Taiwan, Turkey
- 2013-05-20
Not Recruiting
- A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-MASKED STUDY TO EVALUATE THE CLINICAL EFFICACY AND SAFETY OF SHP640 (PVP-IODINE 0.6% AND DEXAMETHASONE 0.1%) OPHTHALMIC SUSPENSION COMPARED TO PVP-IODINE AND PLACEBO IN THE TREATMENT OF ADENOVIRAL CONJUNCTIVITIS.
- -B301 +Conjunctivitis due to adenovirus (H13.1*) +Conjunctivitis due to adenovirus (H13.1*);+Conjunctivitis due to adenovirus (H13.1*)
- Australia, Austria, Canada, Colombia, Estonia, France, Germany, Hungary, India, Israel, Italy, Philippines, Poland, South Africa, Spain, United Kindgdom, United States
- 2018-08-13
Not Recruiting
- To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of Anti-TNF Therapy (SARIL-RA-ASCERTAIN)
- Rheumatoid Arthritis MedDRA version: 16.1 Level: PT Classification code 10039073 Term: Rheumatoid arthritis System Organ Class: 10028395 - Musculoskeletal and connective tissue disorders ;Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
- Argentina, Belgium, Brazil, Colombia, Czech Republic, Estonia, Finland, Hungary, Israel, Italy, Mexico, Netherlands, Norway, Poland, Romania, Russian Federation, Spain, Sweden, United Kingdom, United States
- 2013-01-03
Not recruiting
- To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)
- Rheumatoid Arthritis;Rheumatoid Arthritis;Rheumatoid Arthritis;Rheumatoid Arthritis
- Argentina, Australia, Austria, Brazil, Canada, Chile, Colombia, Czech Republic, Czechia, Ecuador, Germany, Greece, Guatemala, Hong Kong, Hungary, Israel, Italy, Korea, Republic of, Lithuania, Mexico, New Zealand, Peru, Poland, Portugal, Romania, Russian Federation, Slovakia, Spain, Taiwan, Turkey, Ukraine, United States
- 2012-10-15
Not recruiting
- Trial on Effectiveness Combined Probiotics in Atopic Dermatitis in Children
- Atopic Dermatitis;Atopic Dermatitis;Atopic Dermatitis;Atopic Dermatitis
- Brazil
- 2015-08-04
Not Recruiting
- A long term clinical study to determine the effect of albiglutide, when added to standard blood glucose lowering therapies, on major cardiovascular events in patients with Type 2 diabetes
- Diabetes mellitus type 2 MedDRA version: 17.1 Level: LLT Classification code 10045242 Term: Type II diabetes mellitus System Organ Class: 100000004861 ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Argentina, Belgium, Brazil, Bulgaria, Canada, Chile, Colombia, Czech Republic, Denmark, France, Germany, Greece, Hong Kong, Hungary, Italy, Korea, Republic of, Mexico, Netherlands, Norway, Peru, Philippines, Poland, Puerto Rico, Russian Federation, South Africa, Spain, Sweden, Taiwan, Thailand, Ukraine, United Kingdom, United States
- 2015-01-08
Not recruiting
- Impact of Vitamin D Supplementation on Severity of Pediatric Atopic Dermatitis
- Atopic Dermatitis
- Chile
- 2013-11-11
Not Recruiting
- Do patients with social anxiety disorder who receive psychotherapy have any benefits if additional treatment with an antidepressant is added?
- Social anxiety disorder Mental and Behavioural Disorders
- Brazil
- 2018-02-02
Not recruiting
- A Study of Avastin (Bevacizumab) Added to a Chemotherapeutic Regimen in Patients With Metastatic Pancreatic Cancer
- Pancreatic Cancer;Pancreatic Cancer;Pancreatic Cancer;Pancreatic Cancer
- Australia, Austria, Belgium, Canada, China, Czech Republic, Finland, France, Germany, Israel, Italy, Netherlands, New Zealand, Peru, Poland, Singapore, South Africa, Spain, Sweden, Taiwan, United Kingdom
- 2010-10-04
Not recruiting
- The CANTATA-MP Trial (CANagliflozin Treatment and Trial Analysis - Metformin and Pioglitazone)
- Diabetes Mellitus, Type 2;Diabetes Mellitus, Type 2;Diabetes Mellitus, Type 2;Diabetes Mellitus, Type 2
- Brazil, Canada, Finland, France, Germany, Greece, India, Ireland, Mexico, Portugal, Spain, Thailand, United Kingdom, United States
- 2010-04-01